Drugmaker Cipla expands local manufacturing capacity
Bigger production facility in Dube Tradeport to be used
24 October 2019 - 17:31
Indian generic drug manufacturer Cipla is planning to move its growing SA production capacity into a bigger facility in the Dube Tradeport special economic zone it had originally earmarked for manufacturing hi-tech biosimilar drugs.
In 2016 Cipla announced plans for a R1.3bn investment in production of biosimilar drugs in SA, saying at the time that it planned to begin production in 2018. But the project was put on ice after the drugmaker decided to back out of manufacturing these complex products in-house as part of a broader restructuring process...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.